跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CODIPRONT CAPSULE - HSA Drug Approval Details
Approvals
/
HSA
/
CODIPRONT CAPSULE
Approved
THERAPEUTIC
CODIPRONT CAPSULE
CTS CHEMICAL INDUSTRIES LTD (ISRAEL)
🇸🇬 Health Sciences Authority
Approval Date
Jul 30, 2007
Approval ID
eaa25f02c23963bf
Company
CTS CHEMICAL INDUSTRIES LTD (ISRAEL)
Type
Therapeutic
Approval Details
Approval Id
eaa25f02c23963bf
Drug Name
CODIPRONT CAPSULE
Product Name
CODIPRONT CAPSULE
Approval Number
SIN13319P
Approval Date
2007-07-30
Registrant
RX PHARMA PTE. LTD.
Licence Holder
RX PHARMA PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PHARMACY ONLY MEDICINES
Dosage Form
CAPSULE, EXTENDED RELEASE
Route Of Administration
ORAL
Atc Code
R05DA20
Atc Item Name
combinations
Pharma Manufacturer Name
RX PHARMA PTE. LTD.
Active Ingredients
Codeine Base ( as Codeine Phosphate Hemihydrate)
30mg
PHENYLTOLOXAMINE CITRATE EQV PHENYLTOLOXAMINE BASE
10mg
CODEINE BASE (AS CODEINE PHOSPHATE HEMIHYDRATE)
30 MG
PHENYLTOLOXAMINE CITRATE EQV PHENYLTOLOXAMINE BASE
10 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jul 30, 2007
Approval ID
eaa25f02c23963bf
Type
Therapeutic
Back to HSA Approvals